Hematopoietic stem cell transplantation (HSCT) is the only established curative treatment for
sickle cell disease (SCD), a debilitating red blood cell (RBC) disorder with significant …

This study aimed to compare the sensitivity and accuracy of two methods of quantitative real‐
time polymerase chain reaction (qrt‐PCR), in order to determine haematopoietic chimerism …

Haploidentical hematopoietic-cell transplantation using post-transplant cyclophosphamide
(Haplo-PTCy) is a feasible procedure in children with haematologic malignancies. However …

In acute myeloid leukemia (AML), the selection of poor‐risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high post …

Approximately 40 cases of DCL have been reported in the literature; cases have been
reported after allografts from bone marrow, peripheral blood and cord blood. The study of …

After hematopoietic stem cell transplantation, chimerism assay is a useful approach to
monitor the success of the transplant and to select the appropriate treatment strategy, such …

Background Acute lymphoblastic leukemia (ALL) remains one of the most difficult-to-cure
hematological malignancies. Allogeneic hematopoietic stem cell transplantation (HSCT) …

The monitoring of chimerism is a standard procedure to assess engraftment and
achievement of full donor lymphoid cells after reduced intensity conditioning (RIC) stem cell …

Abstract Analysis of short tandem repeats (STR) by PCR analysis is routinely used in
chimerism diagnostics to monitor donor engraftment and to diagnose relapse. Some …

Allogeneic hematopoietic stem cell transplantation (alloHCT) represents the only potentially
curative treatment in high-risk AML patients, but up to 40% of patients suffer from relapse …